AI Accelerates Drug Discovery
Pharmaceutical companies like Sun Pharma and Glenmark are increasingly using artificial intelligence to accelerate drug discovery. In a related development, biotech firm Nuclera and structural biology company leadXpro have partnered to speed up structure-based drug design, a field combining computational biology and chemistry.
- The global AI in drug discovery market was valued at USD 3 billion in 2022 and is projected to reach USD 7.94 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2%. Another report projects the market to grow from USD 3.6 billion in 2024 to USD 49.5 billion by 2034, at a CAGR of 30.1%. - AI platforms can significantly shorten the drug development timeline. For example, Insilico Medicine developed a drug candidate for idiopathic pulmonary fibrosis that reached Phase 2 clinical trials in under 30 months. In another instance, researchers used an AI algorithm to create and test a new drug candidate in just 46 days. - A major application of AI is in repurposing existing drugs for new therapeutic uses. By analyzing vast amounts of biomedical data, BenevolentAI identified an existing rheumatoid arthritis drug, baricitinib, as a potential treatment for ALS, leading to a new clinical trial. - In a tech-focused role like a computational biologist, a typical day involves working on a high-performance computing cluster, writing code to process and analyze biological data, and meeting with researchers to discuss project goals. These professionals often have a background in life sciences, computer science, and mathematics. - A patient-facing role, such as a clinical research associate, involves more direct human interaction, including recruiting and screening patients for trials, collecting data, and ensuring studies comply with regulations. This career path often requires strong communication and data analysis skills. - The educational path for a computational biologist often involves a bachelor's degree in a field like biology or computer science, followed by a master's or Ph.D. in bioinformatics or computational biology. In contrast, a clinical research role may be accessible with a bachelor's degree in a life science, with further specialization available through certifications and master's programs in clinical research. - AI is not replacing scientists; instead, it is augmenting their work by automating data analysis and generating new hypotheses. This allows researchers to focus on the experimental and clinical aspects of drug development. - Key AI technologies used in drug discovery include machine learning, deep learning, and natural language processing. These tools help identify new drug targets, predict how molecules will behave, and extract insights from scientific literature.
